A role for methyl-CpG binding domain protein 2 in the modulation of the estrogen response of pS2/TFF1 gene

PLoS ONE

Volumn 5, Issue 3, 2010, Pages

  Chatagnon, Amandine ^a   Ballestar, Esteban ^b   Esteller, Manel ^b   Dante, Robert ^a  

^a INSERM   (France)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; BISULFITE; DNA; ESTRADIOL; ESTROGEN; ESTROGEN INDUCED BREAST CANCER ASSOCIATED PROTEIN; ESTROGEN RECEPTOR ALPHA; HISTONE H3; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; REGULATOR PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; MBD2 PROTEIN, HUMAN; TFF1 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; BINDING SITE; BREAST CANCER; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMETHYLATION; DNA METHYLATION; ENHANCER REGION; ESTROGEN RESPONSIVE ELEMENT; GENE; GENE EXPRESSION REGULATION; GENE STRUCTURE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROMOTER REGION; PROTEIN DNA BINDING; PROTEIN FUNCTION; PROTEIN PROCESSING; PS 2 GENE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TATA BOX; TRANSCRIPTION REGULATION; BIOLOGICAL MODEL; BIOPSY; CHEMISTRY; DNA MICROARRAY; GENE SILENCING; HELA CELL; METABOLISM; METHODOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

BINDING SITES; BIOPSY; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA METHYLATION; DNA-BINDING PROTEINS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HELA CELLS; HUMANS; MODELS, BIOLOGICAL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 77950403265     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0009665     Document Type: Article

References (56)

1. Ehrlich M (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21: 5400-5413.
2. Esteller M (2007) Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 8: 286-298.
3. Baylin SB, Ohm JE (2006) Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction? Nat Rev Cancer 6: 107-116.
4. Masiakowski P, Breathnach R, Bloch J, Gannon F, Krust A, et al. (1982) Cloning of cDNA sequences of hormone-regulated genes from the MCF-7 human breast cancer cell line. Nucleic Acids Res 10: 7895-7903.
5. Brown AM, Jeltsch JM, Roberts M, Chambon P (1984) Activation of pS2 gene transcription is a primary response to estrogen in the human breast cancer cell line MCF-7. Proc Natl Acad Sci U S A 81: 6344-6348.
6. Amiry N, Kong X, Muniraj N, Kannan N, Grandison PM, et al. (2009) Trefoil factor-1 (TFF1) enhances oncogenicity of mammary carcinoma cells. Endocrinology 150: 4473-4483.
7. Perry JK, Kannan N, Grandison PM, Mitchell MD, Lobie PE (2008) Are trefoil factors oncogenic? Trends Endocrinol Metab 19: 74-81.
8. Martin V, Ribieras S, Song-Wang XG, Lasne Y, Frappart L, et al. (1997) Involvement of DNA methylation in the control of the expression of an estrogen-induced breast-cancer-associated protein (pS2) in human breast cancers. J Cell Biochem 65: 95-106.
9. Dietrich D, Lesche R, Tetzner R, Krispin M, Dietrich J, et al. (2009) Analysis of DNA methylation of multiple genes in microdissected cells from formalin-fixed and paraffin-embedded tissues. J Histochem Cytochem 57: 477-489.
10. Cedar H (1988) DNA methylation and gene activity. Cell 53: 3-4.
11. Huang LH, Wang R, Gama-Sosa MA, Shenoy S, Ehrlich M (1984) A protein from human placental nuclei binds preferentially to 5-methylcytosine-rich DNA. Nature 308: 293-295.
12. Meehan RR, Lewis JD, McKay S, Kleiner EL, Bird AP (1989) Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 58: 499-507.
13. Keshet I, Lieman-Hurwitz J, Cedar H (1986) DNA methylation affects the formation of active chromatin. Cell 44: 535-543.
14. Hendrich B, Bird A (1998) Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 18: 6538-6547.
15. Bird AP, Wolffe AP (1999) Methylation-induced repression - belts, braces, and chromatin. Cell 99: 451-454.
16. Fatemi M, Wade PA (2006) MBD family proteins: reading the epigenetic code. J Cell Sci 119: 3033-3037.
17. Klose RJ, Bird AP (2006) Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31: 89-97.
18. Saito M, Ishikawa F (2002) The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2. J Biol Chem 277: 35434-35439.
19. Wade PA, Gegonne A, Jones PL, Ballestar E, Aubry F, et al. (1999) Mi-2 complex couples DNA methylation to chromatin remodelling and histone deacetylation. Nat Genet 23: 62-66.
20. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, et al. (1999) Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 13: 1924-1935.
21. Hendrich B, Hardeland U, Ng HH, Jiricny J, Bird A (1999) The thymine glycosylase MBD4 can bind to the product of deamination at methylated CpG sites. Nature 401: 301-304.
22. Delaval K, Feil R (2004) Epigenetic regulation of mammalian genomic imprinting. Curr Opin Genet Dev 14: 188-195.
23. Barr H, Hermann A, Berger J, Tsai HH, Adie K, et al. (2007) Mbd2 contributes to DNA methylation-directed repression of the Xist gene. Mol Cell Biol 27: 3750-3757.
24. Jaenisch R, Bird A (2003) Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 33 Suppl. pp 245-254.
25. Lorincz MC, Dickerson DR, Schmitt M, Groudine M (2004) Intragenic DNA methylation alters chromatin structure and elongation efficiency in mammalian cells. Nat Struct Mol Biol 11: 1068-1075.
26. Auriol E, Billard LM, Magdinier F, Dante R (2005) Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus. Nucleic Acids Res 33: 4243-4254.
27. Boyes J, Bird A (1992) Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. Embo J 11: 327-333.
28. Curradi M, Izzo A, Badaracco G, Landsberger N (2002) Molecular mechanisms of gene silencing mediated by DNA methylation. Mol Cell Biol 22: 3157-3173.
29. Rio MC, Bellocq JP, Gairard B, Rasmussen UB, Krust A, et al. (1987) Specific expression of the pS2 gene in subclasses of breast cancers in comparison with expression of the estrogen and progesterone receptors and the oncogene ERBB2. Proc Natl Acad Sci U S A 84: 9243-9247.
30. Perrin D, Ballestar E, Fraga MF, Frappart L, Esteller M, et al. (2007) Specific hypermethylation of LINE-1 elements during abnormal overgrowth and differentiation of human placenta. Oncogene 26: 2518-2524.
31. Metzger D, Berry M, Ali S, Chambon P (1995) Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol Endocrinol 9: 579-591.
32. Billard LM, Magdinier F, Lenoir GM, Frappart L, Dante R (2002) MeCP2 and MBD2 expression during normal and pathological growth of the human mammary gland. Oncogene 21: 2704-2712.
33. Nunez AM, Berry M, Imler JL, Chambon P (1989) The 5′ flanking region of the pS2 gene contains a complex enhancer region responsive to oestrogens, epidermal growth factor, a tumour promoter (TPA), the c-Ha-ras oncoprotein and the c-jun protein. Embo J 8: 823-829.
34. Metivier R, Penot G, Hubner MR, Reid G, Brand H, et al. (2003) Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter. Cell 115: 751-763.
35. Metivier R, Penot G, Carmouche RP, Hubner MR, Reid G, et al. (2004) Transcriptional complexes engaged by apo-estrogen receptor-alpha isoforms have divergent outcomes. Embo J 23: 3653-3666.
36. Zinn RL, Pruitt K, Eguchi S, Baylin SB, Herman JG (2007) hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site. Cancer Res 67: 194-201.
37. Renaud S, Loukinov D, Abdullaev Z, Guilleret I, Bosman FT, et al. (2007) Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene. Nucleic Acids Res 35: 1245-1256.
38. Sahar S, Sassone-Corsi P (2007) Circadian clock and breast cancer: a molecular link. Cell Cycle 6: 1329-1331.
39. Garcia-Bassets I, Kwon YS, Telese F, Prefontaine GG, Hutt KR, et al. (2007) Histone methylation-dependent mechanisms impose ligand dependency for gene activation by nuclear receptors. Cell 128: 505-518.
40. Magdinier F, Wolffe AP (2001) Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Proc Natl Acad Sci U S A 98: 4990-4995.
41. Nguyen CT, Gonzales FA, Jones PA (2001) Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation. Nucleic Acids Res 29: 4598-4606.
42. Lopez-Serra L, Ballestar E, Fraga MF, Alaminos M, Setien F, et al. (2006) A Profile of Methyl-CpG Binding Domain Protein Occupancy of Hypermethylated Promoter CpG Islands of Tumor Suppressor Genes in Human Cancer. Cancer Res 66: 8342-8346.
43. Ballestar E, Paz MF, Valle L, Wei S, Fraga MF, et al. (2003) Methyl-CpG binding proteins identify novel sites of epigenetic inactivation in human cancer. Embo J 22: 6335-6345.
44. Martin V, Ribieras S, Rio MC, Dante R (1998) The estrogen responsive element of the pS2 gene is recognized by a methylation sensitive DNA binding protein. Biol Chem 379: 409-416.
45. Giamarchi C, Solanas M, Chailleux C, Augereau P, Vignon F, et al. (1999) Chromatin structure of the regulatory regions of pS2 and cathepsin D genes in hormone-dependent and -independent breast cancer cell lines. Oncogene 18: 533-541.
46. Pao MM, Tsutsumi M, Liang G, Uzvolgyi E, Gonzales FA, et al. (2001) The endothelin receptor B (EDNRB) promoter displays heterogeneous, site specific methylation patterns in normal and tumor cells. Hum Mol Genet 10: 903-910.
47. Kangaspeska S, Stride B, Metivier R, Polycarpou-Schwarz M, Ibberson D, et al. (2008) Transient cyclical methylation of promoter DNA. Nature 452: 112-115.
48. Metivier R, Gallais R, Tiffoche C, Le Peron C, Jurkowska RZ, et al. (2008) Cyclical DNA methylation of a transcriptionally active promoter. Nature 452: 45-50.
49. Probst AV, Dunleavy E, Almouzni G (2009) Epigenetic inheritance during the cell cycle. Nat Rev Mol Cell Biol 10: 192-206.
50. Morgan HD, Santos F, Green K, Dean W, Reik W (2005) Epigenetic reprogramming in mammals. Hum Mol Genet 14 Spec No 1: R47-58.
51. Jin SG, Guo C, Pfeifer GP (2008) GADD45A does not promote DNA demethylation. PLoS Genet 4: e1000013.
52. Barreto G, Schafer A, Marhold J, Stach D, Swaminathan SK, et al. (2007) Gadd45a promotes epigenetic gene activation by repair-mediated DNA demethylation. Nature 445: 671-675.
53. Ooi SK, Bestor TH (2008) The colorful history of active DNA demethylation. Cell 133: 1145-1148.
54. Martinowich K, Hattori D, Wu H, Fouse S, He F, et al. (2003) DNA methylation-related chromatin remodeling in activity-dependent BDNF gene regulation. Science 302: 890-893.
55. Chen WG, Chang Q, Lin Y, Meissner A, West AE, et al. (2003) Derepression of BDNF transcription involves calcium-dependent phosphorylation of MeCP2. Science 302: 885-889.
56. Hutchins AS, Mullen AC, Lee HW, Sykes KJ, High FA, et al. (2002) Gene silencing quantitatively controls the function of a developmental trans-activator. Mol Cell 10: 81-91.